In the last quarter of 2004, Pliva's year-on-year profits were down by 50 per cent, while royalties from azithromycin dropped by as much as 11.4 per cent.
U poslednjem kvartalu 2004. godine Plivin profit u odnosu na prethodnu godinu pao je za 50 odsto, dok je dobit od patenta za azitromicin pala za čak 11,4 procenta.